Arcellx, Inc.
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-03-10
Analyst
Lyric Partners
Equibles does not estimate personal net worth.
Dana Graybosch is recorded as Analyst at Lyric Partners. Dana Graybosch has spoken on 2 investor events across 2 companies, most recently for Arcellx, Inc. on March 10, 2026. Those appearances were for Arcellx, Inc. and Gilead Sciences, Inc. (GILD). The companies whose calls Dana Graybosch spoke on are classified in the Healthcare sector.
“I'm a senior equity research analyst here at Lyrinc Partners. And I'm excited to be hosting management from Gilead this morning. We have Dietmar and Andy. We have 30 minutes, which isn't sufficient time to get through that much.”
“I'm a senior equity research analyst here at Lyrinc Partners. And I'm excited to be hosting management from Gilead this morning. We have Dietmar and Andy. We have 30 minutes, which isn't sufficient time to get through that much.”
Lyric Partners
Analyst
Transcript header (unverified)
Arcellx, Inc.
Biotechnology · Healthcare
Drug Manufacturers - General · Healthcare
Leerink Partners Global Healthcare Conference
Arcellx, Inc.